April 11, 2022 — Mount Sinai researchers have developed a novel method to identify aggressive early-stage lung cancers and target drugs known as aurora kinase inhibitors to tumors that are especially likely to respond to them.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now